The single biggest risk factor for the vast majority of chronic diseases is old age. For many diseases, in fact, a person's birth date is a larger red flag than all other known risk factors combined. But for too long, physicians thought that the aging process was impossible to modify or slow down. Like death and taxes, growing old—and the medical problems that come with it—was considered inevitable. That's starting to change. In this special news focus on aging, Nature Medicine looks at the progress being made in drug interventions for the elderly and the hurdles that remain in the pursuit of a pharmaceutical elixir for healthy aging.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gordon, L.B. et al. Proc. Natl. Acad. Sci. USA 41, 16666–16671 (2012).
Eriksson, M. et al. Nature 423, 293–298 (2003).
Scaffidi, P. & Misteli, T. Science 312, 1059–1063 (2006).
Cao, K. et al. Sci. Transl. Med. 3, 89ra58 (2011).
Liu, B. et al. Cell. Metab. 16, 738–750 (2012).
Rights and permissions
About this article
Cite this article
Jiang, K. Drug development for progeria yields insights into normal aging. Nat Med 19, 515 (2013). https://doi.org/10.1038/nm0513-515
Published:
Issue date:
DOI: https://doi.org/10.1038/nm0513-515